PDE4 inhibitor upregulates PTH-induced osteoclast formation via CRE-mediated COX-2 expression in osteoblasts (Q44039848)

29 November 2017

title

PDE4 inhibitor upregulates PTH-induced osteoclast formation via CRE-mediated COX-2 expression in osteoblasts (English)

1 reference

29 November 2017

0 references

Hyojung Park

1

1 reference

29 November 2017

A Long Sae Mi No

2

1 reference

29 November 2017

Jung-Min Lee

3

1 reference

29 November 2017

Ling Chen

4

1 reference

29 November 2017

Soo Young Lee

5

1 reference

29 November 2017

Dong-Seok Lee

6

1 reference

29 November 2017

Mijung Yim

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

29 November 2017

1 reference

29 November 2017

volume

584

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

173-180

1 reference

Osteoblastic cells are involved in osteoclast formation.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name...

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Involvement of phosphodiesterase isozymes in osteoblastic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

PTH and PTHrP signaling in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

Teriparatide: a review of its use in osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.11.043

10.1016/J.FEBSLET.2009.11.043

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference